Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: review of literature results

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

1995 • 2,804 citations

Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials

1996 • 2,541 citations

Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

2000 • 2,156 citations

Measuring the quality of life of cancer patients

1981 • 1,562 citations

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

1984 • 1,063 citations

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1990 • 900 citations

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1999 • 875 citations

The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials

1994 • 814 citations

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1993 • 498 citations

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

1999 • 458 citations

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1993 • 394 citations

Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome

2000 • 333 citations

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)

2000 • 312 citations

Chemotherapy vs Supportive Care in Advanced Non-Small-Cell Lung Cancer

1994 • 307 citations

Randomized Trial of Paclitaxel Plus Supportive Care Versus Supportive Care for Patients With Advanced Non-Small-Cell Lung Cancer

2000 • 305 citations

Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS)

1993 • 293 citations

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.

1986 • 242 citations

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

1989 • 207 citations

Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy

1999 • 153 citations

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial

1998 • 130 citations

ON THE RELATIONSHIP BETWEEN RESPONSE TO TREATMENT AND SURVIVAL TIME

1996 • 130 citations

Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party

1997 • 85 citations

SUMMARY MEASURES AND STATISTICS FOR COMPARISON OF QUALITY OF LIFE IN A CLINICAL TRIAL OF CANCER THERAPY

1997 • 83 citations

Assessing the quality of life of patients in cancer clinical trials: Common problems and common sense solutions

1992 • 78 citations

A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931

1997 • 34 citations

Best Supportive Care or Chemotherapy for Stage IV Non-Small Cell Lung Cancer

1999 • 16 citations

Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implications

1989 • 15 citations

Role of paclitaxel in combined modality therapy for locally advanced non-small cell lung cancer (NSCLC): Multiinstitutional trials exploring sequential phase II studies of paclitaxel +/− carboplatin and radiation therapy (+/−hyperfractionation: HFXRT)

2000 • 6 citations

Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC): Review of the Southwest Oncology Group (SWOG) database

2000 • 3 citations